Pierrette Gaudreau

Accredited Professor

Contact Information

Département de médecine
Laboratoire de neuroendocrinologie du vieillissement
Centre de Recherche du CHUM
900, rue St-Denis, Tour Viger, Bureau R05.436B-02
Montréal (Québec)
H2X 0A9

.

T 514 890-8000, poste 23613
pierrette.gaudreau@umontreal.ca

Themes

Characterization, function and regulation of the pituitary and renal growth hormone-releasing hormone receptor and its isoforms. Study of hypothalamo-pituitary somatotroph axis mechanisms of regulation, using animal model of successful aging (nutritional or hormonal interventions): molecular, cellular and functional approaches. Longitudinal study of a cohort of aged people, on nutrition as a determinant of successful aging, including nutrigenetics and nutrigenomics.

Publications

  • Boisvert, C., Paré, C., Veyrat-Durebex, C., Robert, A., Dubuisson, S., Morel, G. and Gaudreau P. Localization and regulation of a functional growth hormone-releasing hormone receptor in the rat kidney. Endocrinology, 143: 1475-1484, 2002
  • Veyrat-Durebex C, Pomerleau L, Langlois D, Gaudreau P.  Internalization and trafficking of the human and rat growth hormone-releasing hormone receptor. J Cell Physiol, published Online, October 21, 2004; published 203: 335-344, 2005.
  • Veyrat-Durebex C, Alliot J, Gaudreau P. Regulation of the pituitary growth hormone-releasing hormone receptor in male and female aging Lou rats:  new insights into successful aging.  J Neuroendocrinol 17:691-700, 2005. IF: 2.774
  • Gaudreau P, Morais JA, Shatenstein B, Gray-Donald K, Khalil A, Dionne I, Ferland G, Fülöp T, Jacques D, Kergoat MJ, Tessier D, Wagner R, Payette H. Nutrition as a Determinant of Successful Aging: Description of the Quebec Longitudinal Study NuAge and results from cross-sectional pilot studies. Rejuvenation Res, 10: 377-386, 2007.
  • Bédard K*, StreckoJ*, Theriault K, Bédard J, Veyrat-Durebex C, Gaudreau P. Effects of a high-glucose environment on the pituitary growth hormone-releasing hormone receptor: type 1 diabetes compared to in vitro glucotoxicity. Am J Physiol-Endocrinol Metab, 294; E740-751, 2008 . Feb 19 2008 [Epub ahead of print] PMID: 18285528 [PubMed – as supplied by publisher]. IF: 4.123